Changes to the ways in which the FDA plans to regulate vaccines represent a threat to effective vaccines and public health, ...

A topical hair loss medication successfully built up hair in a Phase 3 trial, according to the results of two late stage ...

The move comes a day after Richard Pazdur, a top FDA official and Michele’s boss, announced his decision to retire.

Six primary care providers at a single Mass General Brigham practice are moving to rival Beth Israel Lahey Health in January, ...

As hospitals study the impact of AI scribes, they are finding that clinicians love the tools, even if they don’t save that ...

Retro Bio, a longevity startup backed by OpenAI CEO Sam Altman, is close to raising what could be one of the drug industry’s ...

Former CDC official Demetre Daskalakis is taking his skills back to New York, where they were honed in HIV clinics and the ...

Capricor Therapeutics said Wednesday that its cell therapy significantly improved muscle and heart function in patients with ...

Crisis pregnancy centers — faux health clinics designed to deter pregnant people from getting abortions — are back at the ...

A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...

ACIP has drifted toward inflating speculative risks while downplaying well-established vaccine benefits,” write former CDC ...

WASHINGTON — A new health care advocacy group, which will represent the shrinking number of independent doctors in America, ...